glp-1 forum Semaglutide & tirzepatide are transforming diabetes & obesity management. These receptor agonists offer benefits from glycemic control to weight loss and cardiovascular risk reduction, emphasizing their broad impact. Read more from GLP-1-Based Therapeutics Summit | pharmaphorum

Learn about Zepbound (tirzepatide) for weight loss

Learn key deadlines, compliance, and alternatives.

Pharmacists, get information about RYBELSUS tablets, a once-daily oral medication indicated to treat adults with type 2 diabetes

Looking to manage your weight without constant hunger

Loss of muscle mass and strength not only impairs mobility and quality of life, but also worsens insulin resistance, accelerates cardiometabolic decline and increases mortality risk

Results In total, 204 cases of SSIBs associated with GLP-1RAs, including semaglutide, liraglutide, dulaglutide, exenatide, and albiglutide, were identified in the FAERS database